|
The EU's drug watchdog on Thursday recommended for approval AstraZeneca's Covid-19 prevention jab, which can be used for patients with immune system problems or severe reactions to normal vaccines.
The European Medicines Agency's human medicines committee ‘has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca for the prevention of Covid-19 in adults and adolescents from 12 years of age,’ the Amsterdam-based EMA said in a statement.
Shares in AstraZeneca closed up 1.3% at 9,856.00 pence in London on Thursday.
source: AFP
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
